Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

710 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Health-Status Outcomes in Older Patients With Myocardial Infarction: Physiology-Guided Complete Revascularization Versus Culprit-Only Strategy.
Campo G, Guiducci V, Escaned J, Moreno R, Casella G, Cavazza C, Cerrato E, Contarini M, Arena M, Iniguez Romo A, Gutiérrez Ibañes E, Scarsini R, Vadalà G, Andò G, Pilato G, Musto d'Amore S, Capecchi A, Trillo Nouche R, Moscarella E, Gambino A, Pavani M, Zanetti A, Pesenti N, Dudek D, Barbato E, Tebaldi M, Biscaglia S. Campo G, et al. Among authors: barbato e. Circ Cardiovasc Qual Outcomes. 2024 Jul;17(7):e010490. doi: 10.1161/CIRCOUTCOMES.123.010490. Epub 2024 Jun 18. Circ Cardiovasc Qual Outcomes. 2024. PMID: 38887951 Free article. Clinical Trial.
Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding Risk: A Randomized Clinical Trial.
Erriquez A, Campo G, Guiducci V, Escaned J, Moreno R, Casella G, Menozzi M, Cerrato E, Sacchetta G, Menozzi A, Santos IA, Ibañes EG, Scarsini R, Vadalà G, Andò G, Díez-Gil JL, d'Amore SM, Capecchi A, Colaiori I, Gallo F, Pavasini R, Marrone A, Pompei G, Lanzilotti V, Dudek D, Barbato E, Tebaldi M, Biscaglia S. Erriquez A, et al. Among authors: barbato e. JAMA Cardiol. 2024 Jun 1;9(6):565-573. doi: 10.1001/jamacardio.2024.0804. JAMA Cardiol. 2024. PMID: 38717753 Clinical Trial.
Coronary microvascular dysfunction beyond the spectrum of chronic coronary syndromes.
Belmonte M, Foà A, Paolisso P, Bergamaschi L, Gallinoro E, Polimeni A, Scarsini R, Muscoli S, Amicone S, De Vita A, Villano A, Angeli F, Armillotta M, Sucato V, Tremamunno S, Morrone D, Indolfi C, Filardi PP, Ribichini F, Lanza GA, Chieffo A, Barbato E, Pizzi C; Coronary Physiopathology and Microcirculation Working Group of the Italian Society of Cardiology (SIC). Belmonte M, et al. Among authors: barbato e. Prog Cardiovasc Dis. 2024 Oct 22:S0033-0620(24)00142-7. doi: 10.1016/j.pcad.2024.10.006. Online ahead of print. Prog Cardiovasc Dis. 2024. PMID: 39447854 Review.
Clinical characteristics and outcomes of Takotsubo syndrome in patients with chronic obstructive pulmonary disease.
Arcari L, Tini G, Zuccanti M, Camastra G, Cianca A, Belmonte E, Montefusco G, Scirpa R, Malerba C, Lupparelli F, Sclafani M, Maestrini V, Musumeci B, Barbato E, Cacciotti L. Arcari L, et al. Among authors: barbato e. Eur J Intern Med. 2024 Nov 7:S0953-6205(24)00448-5. doi: 10.1016/j.ejim.2024.10.026. Online ahead of print. Eur J Intern Med. 2024. PMID: 39510864 Free article.
Correction: Intentional coronary revascularization versus conservative therapy in patients after peripheral artery revascularization due to critical limb ischemia: the INCORPORATE trial.
Toth GG, Brodmann M, Schnur SSK, Bartus S, Vrsalovic M, Krestianinov O, Kala P, Bil J, Gil R, Kanovsky J, Di Serafino L, Paolucci L, Barbato E, Mangiacapra F, Ruzsa Z. Toth GG, et al. Among authors: barbato e. Clin Res Cardiol. 2024 Jul 24. doi: 10.1007/s00392-024-02501-7. Online ahead of print. Clin Res Cardiol. 2024. PMID: 39046473 No abstract available.
Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.
De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, Jagic N, Möbius-Winkler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engström T, Oldroyd KG, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Jüni P, Fearon WF; FAME 2 Trial Investigators. De Bruyne B, et al. Among authors: barbato e. N Engl J Med. 2012 Sep 13;367(11):991-1001. doi: 10.1056/NEJMoa1205361. Epub 2012 Aug 27. N Engl J Med. 2012. PMID: 22924638 Free article. Clinical Trial.
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events.
Marfella R, Prattichizzo F, Sardu C, Fulgenzi G, Graciotti L, Spadoni T, D'Onofrio N, Scisciola L, La Grotta R, Frigé C, Pellegrini V, Municinò M, Siniscalchi M, Spinetti F, Vigliotti G, Vecchione C, Carrizzo A, Accarino G, Squillante A, Spaziano G, Mirra D, Esposito R, Altieri S, Falco G, Fenti A, Galoppo S, Canzano S, Sasso FC, Matacchione G, Olivieri F, Ferraraccio F, Panarese I, Paolisso P, Barbato E, Lubritto C, Balestrieri ML, Mauro C, Caballero AE, Rajagopalan S, Ceriello A, D'Agostino B, Iovino P, Paolisso G. Marfella R, et al. Among authors: barbato e. N Engl J Med. 2024 Mar 7;390(10):900-910. doi: 10.1056/NEJMoa2309822. N Engl J Med. 2024. PMID: 38446676 Free PMC article.
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.
Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators. Ray KK, et al. Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Lancet Diabetes Endocrinol. 2019. PMID: 31272931 Free article. Clinical Trial.
710 results